Fibroblastic reaction and vascular maturation in human colon cancers

International Journal of Radiation Biology

Volumn 85, Issue 11, 2009, Pages 1013-1025

  Schmid, Stephan A ^a,b   Dietrich, Antje ^c   Schulte, Stephanie ^d   Gaumann, Andreas ^a   Kunz Schughart, Leoni A ^c  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Colon cancer; Endothelial cells; Fibroblast; Microvessel counting; Tumour stroma

Indexed keywords

ANIMAL TISSUE; ARTICLE; CANCER CELL; CELL STRAIN HCT116; COLON CANCER; CONTROLLED STUDY; ENGRAFTMENT; FIBROBLAST; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VIVO STUDY; MAJOR CLINICAL STUDY; MICROVASCULATURE; MORPHOLOGY; MORPHOMETRICS; MOUSE; NONHUMAN; PERICYTE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SKIN GRAFT; XENOGRAFT;

ANIMALS; CELLS, CULTURED; COLONIC NEOPLASMS; CYTOKINE RECEPTOR COMMON BETA SUBUNIT; FEMALE; FIBROBLASTS; HCT116 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PERICYTES; STROMAL CELLS; TRANSPLANTATION, HETEROLOGOUS;

MUS;

EID: 70449481049     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.3109/09553000903258897     Document Type: Article

References (66)

1. Barsky SH, Nelson LL, Levy VA. 1987. Tumour desmoplasia inhibits angiogenesis. Lancet 2:1336-1337.
2. Benjamin LE, Golijanin D, Itin A, Pode D, Keshet E. 1999. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal [see comments]. Journal of Clinical Investigation 103:159-165.
3. Benjamin LE, Hemo I, Keshet E. 1998. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 125:1591-1598.
4. Berthod F, Germain L, Tremblay N, Auger FA. 2006. Extracellular matrix deposition by fibroblasts is necessary to promote capillary-like tube formation in vitro. Journal of Cellular Physiology 207:491-498.
5. Bjarnegard M, Enge M, Norlin J, Gustafsdottir S, Fredriksson S, Abramsson A, Takemoto M, Gustafsson E, Fassler R, Betsholtz C. 2004. Endothelium-specific ablation of PDGFB leads to pericyte loss and glomerular, cardiac and placental abnormalities. Development 131:1847-1857.
6. Caporale A, Cosenza UM, Vestri AR, Giuliani A, Costi U, Galati G, Cannaviello C, Franchi F. 2001. Has desmoplastic response extent protective action against tumor aggressiveness in gastric carcinoma? Journal of Experimental and Clinical Cancer Research 20:21-24.
7. Chang HY, Chi JT, Dudoit S, Bondre C, Van De Rijn M, Botstein D, Brown PO. 2002. Diversity, topographic differentiation, and positional memory in human fibroblasts. Proceedings of the National Academy of Sciences of the United States of America 99:12877-12882.
8. Dalerba P, Dylla SJ, Park IK, Liu R, Wang X, Cho RW, Hoey T, Gurney A, Huang EH, Simeone DM, Shelton, AA, Parmiani G, Castelli C, Clarke MF. 2007. Phenotypic characterization of human colorectal cancer stem cells. Proceedings of the National Academy of Sciences of the United States of America 104:10158-10163.
9. De Wever O, Demetter P, Mareel M, Bracke M. 2008. Stromal myofibroblasts are drivers of invasive cancer growth. International Journal of Cancer 15; 123(10):2229-2238.
10. De Wever O, Nguyen QD, Van Hoorde L, Bracke M, Bruyneel E, Gespach C, Mareel M. 2004. Tenascin-C and SF/HGF produced by myofibroblasts in vitro provide convergent proinvasive signals to human colon cancer cells through RhoA and Rac. FASEB Journal 18(9):1016-1018.
11. Dingemans KP, Zeeman-Boeschoten IM, Keep RF, Das PK. 1993. Transplantation of colon carcinoma into granulation tissue induces an invasive morphotype. International Journal of Cancer 54:1010-1016.
12. Dittfeld C, Dietrich A, Peickert S, Hering S, Baumann M, Grade M, Ried T, Kunz-Schughart LA. 2009. CD133 expression isnot selective for tumor-initiating or radioresistant cell populations in the CRC line HCT-116. Radiotherapy and Oncology.
13. Eberhard A, Kahlert S, Goede V, Hemmerlein B, Plate KH, Augustin HG. 2000. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: Implications for antiangiogenic tumor therapies [published erratum appears in Cancer Res 2000 Jul 1;60(13):3668]. Cancer Research 60:1388-1393.
14. Erber R, Thurnher A, Katsen AD, Groth G, Kerger H, Hammes HP, Menger MD, Ullrich A, Vajkoczy P. 2004. Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms. FASEB Journal 18:338-340.
15. Folkman J. 2002. Role of angiogenesis in tumor growth and metastasis. Seminars in Oncology 29:15-18.
16. Folkman J. 2007a. Angiogenesis: An organizing principle for drug discovery? Nature Reviews Drug Discovery 6:273-286. (Pubitemid 46505878)
17. Folkman J. 2007b. Is angiogenesis an organizing principle in biology and medicine? Journal of Pediatric Surgery 42:1-11. (Pubitemid 46043358)
18. Gilad AA, Israely T, Dafni H Meir G, Cohen B, Neeman M. 2005. Functional and molecular mapping of uncoupling between vascular permeability and loss of vascular maturation in ovarian carcinoma xenografts: The role of stroma cells in tumor angiogenesis. International Journal of Cancer 117:202-211.
19. Gilead A, Meir G, Neeman M. 2004. The role of angiogenesis, vascular maturation, regression and stroma infiltration in dormancy and growth of implanted MLS ovarian carcinoma spheroids. International Journal of Cancer JID - 0042124, 108:524-531.
20. Goede V, Schmidt T, Kimmina S, Kozian D, Augustin HG. 1998. Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis. Laboratory Investigation 78:1385-1394.
21. Granot D, Addadi Y, Kalchenko V, Harmelin A, Kunz-Schughart LA, Neeman M. 2007. In vivo imaging of the systemic recruitment of fibroblasts to the angiogenic rim of ovarian carcinoma tumors. Cancer Research, 67:9180-9189.
22. Greenberg JI, Shields DJ, Barillas SG, Acevedo LM, Murphy E, Huang J, Scheppke L, Stockmann C, Johnson RS, Angle N, Cheresh DA. 2008. A role for VEGF as a negative regulator of pericyte function and vessel maturation. Nature 456:809-813.
23. Halvorsen TB, Seim E. 1989. Association between invasiveness, inflammatory reaction, desmoplasia and survival in colorectal cancer. Journal of Clinical Pathology 42:162-166.
24. Hasebe T, Sasaki S, Imoto S, Mukai K, Yokose T, Ochiai A. 2002. Prognostic significance of fibrotic focus in invasive ductal carcinoma of the breast: A prospective observational study. Modern Pathology 15:502-516.
25. Hellstrom M, Kalen M, Lindahl P, Abramsson A, Betsholtz C. 1999. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 126:3047-3055.
26. Hewitt RE, Powe DG, Carter GI, Turner DR. 1993. Desmoplasia and its relevance to colorectal tumour invasion. International Journal of Cancer 53:62-69.
27. Hughes CC. 2008. Endothelial-stromal interactions in angiogenesis. Current Opinion in Hematology 15:204-209.
28. Iacobuzio-Donahue CA, Argani P, Hempen PM, Jones J, Kern SE. 2002. The desmoplastic response to infiltrating breast carcinoma: Gene expression at the site of primary invasion and implications for comparisons between tumor types. Cancer Research 62:5351-5357.
29. Kalluri R, Weinberg RA. 2009. The basics of epithelial-mesenchymal transition. Journal of Clinical Investigation 119:1420-1428.
30. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, Richardson AL, Polyak K, Tubo R, Weinberg RA. 2007. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449:557-563.
31. Klymkowsky MW, Savagner P. 2009. Epithelial-mesenchymal transition: a cancer researcher's conceptual friend and foe. American Journal of Pathology 174:1588-1593.
32. Koliopanos A, Friess H, Di Mola FF, Tang WH, Kubulus D, Brigstock D, Zimmermann A, Buchler MW. 2002. Connective tissue growth factor gene expression alters tumor progression in esophageal cancer. World Journal of Surgery 26:420-427.
33. Korff T, Kimmina S, Martiny-Baron G, Augustin HG. 2001. Blood vessel maturation in a 3-dimensional spheroidal coculture model: Direct contact with smooth muscle cells regulates endothelial cell quiescence and abrogates VEGF responsiveness. FASEB Journal 15:447-457.
34. Krasna MJ, Flancbaum L, Cody RP, Shneibaum S, Ben Ari G. 1988. Vascular and neural invasion in colorectal carcinoma. Incidence and prognostic significance. Cancer 61:1018-1023.
35. Kunz-Schughart LA, Knuechel R. 2002a. Tumor-associatedfibroblasts (part II): Functional impact on tumor tissue. Histology and Histopathology 17:623-637.
36. Kunz-Schughart LA, Knuechel R. 2002b. Tumor-associated fibroblasts (part I): Active stromal participants in tumor development and progression? Histology Histopathology 17:599-621.
37. Kunz-Schughart LA, Schroeder JA, Wondrak M, Van Rey F, Lehle K, Hofstaedter F, Wheatley DN. 2006. Potential of fibroblasts to regulate the formation of three-dimensional vessel-like structures from endothelial cells in vitro. American Journal of Physiology Cell Physiology 290:C1385-C1398.
38. Liang P, Nakada I, Hong JW, Tabuchi T, Motohashi G, Takemura A, Nakachi T, Kasuga T, Tabuchi T. 2007. Prognostic significance of immunohistochemically detected blood and lymphatic vessel invasion in colorectal carcinoma: Its impact on prognosis. Annals of Surgical Oncology 14:470-477.
39. Lindahl P, Betsholtz C. 1998. Not all myofibroblasts are alike: Revisiting the role of PDGF-A and PDGF-B using PDGFtargeted mice. Current Opinion in Nephrology and Hypertension 7:21-26.
40. Lindahl P, Johansson BR, Leveen P, Betsholtz C. 1997. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277:242-245.
41. Lindblom P, Gerhardt H, Liebner S, Abramsson A, Enge M, Hellstrom M, Backstrom G, Fredriksson S, Landegren U, Nystrom HC, Bergstrom G, Dejana E, Ostman A, Lindahl P, Betsholtz C. 2003. Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall. Genes & Development 17:1835-1840.
42. Liotta LA, Kohn EC. 2001. The microenvironment of the tumour-host interface. Nature 411:375-379.
43. Maeshima AM, Niki T, Maeshima A, Yamada T, Kondo H, Matsuno Y. 2002. Modified scar grade: A prognostic indicator in small peripheral lung adenocarcinoma. Cancer 95:2546-2554.
44. Montesano R, Pepper MS, Orci L. 1993. Paracrine induction of angiogenesis in vitro by Swiss 3T3 fibroblasts. Journal of Cell Science 105(Pt 4):1013-1024.
45. Nakatsu MN, Sainson RC, Aoto JN, Taylor KL, Aitkenhead M, Perez-Del-Pulgar S, Carpenter PM, Hughes CC. 2003. Angiogenic sprouting and capillary lumen formation modeled by human umbilical vein endothelial cells (HUVEC) in fibrin gels: The role of fibroblasts and Angiopoietin-1. Microvascular Research 66:102-112.
46. Naumov GN, Folkman J, Straume O, Akslen LA. 2008. Tumorvascular interactions and tumor dormancy. Acta Pathologica, Microbiologica et Immunologica Scandinavica 116:569-585.
47. Nehls V, Schuchardt E, Drenckhahn D. 1994. The effect of fibroblasts, vascular smooth muscle cells, and pericytes onsprout formation of endothelial cells in a fibrin gel angiogenesis system. Microvascular Research 48:349-363.
48. Noel A, Hajitou A, L'Hoir C, Maquoi E, Baramova E, Lewalle JM, Remacle A, Kebers F, Brown P, Calberg-Bacq CM, Foidart JM. 1998. Inhibition of stromal matrix metalloproteases: Effects on breast-tumor promotion by fibroblasts. International Journal of Cancer 76:267-273.
49. O'Brien CA, Pollett A, Gallinger S, Dick JE. 2007. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445:106-110.
50. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL, Weinberg RA. 2005. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell, 121:335-348.
51. Orimo A, Tomioka Y, Shimizu Y, Sato M, Oigawa S, Kamata K, Nogi Y, Inoue S, Takahashi M, Hata T, Muramatsu M. 2001. Cancer-associated myofibroblasts possess various factors to promote endometrial tumor progression. Clinical Cancer Research 7:3097-3105.
52. Orimo A, Weinberg RA. 2006. Stromal fibroblasts in cancer: A novel tumor-promoting cell type. Cell Cycle 5:1597-1601.
53. Orlidge A, D'Amore PA. 1987. Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. Journal of Cell Biology 105:1455-1462.
54. Polyak K, Haviv I, Campbell IG. 2009. Co-evolution of tumor cells and their microenvironment. Trends in Genetics 25:30-38.
55. Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, West AB. 1999. Myofibroblasts I. Paracrine cells important in health and disease. American Journal of Physiology 277:C1-C9.
56. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, De Maria R. 2007. Identification and expansion of human colon-cancer-initiating cells. Nature 445:111-115.
57. Schmid SA, Gaumann A, Wondrak M, Eckermann C, Schulte S, Mueller-Klieser W, Wheatley DN, Kunz-Schughart LA. 2007. Lactate adversely affects the in vitro formation of endothelial cell tubular structures through the action of TGF-beta1. Experimental Cell Research 313:2531-2549.
58. Silzle T, Kreutz M, Dobler MA, Brockhoff G, Knuechel R, Kunz- Schughart LA. 2003. Tumor-associated fibroblasts recruit blood monocytes into tumor tissue. European Journal of Immunology 33:1311-1320.
59. Sis B, Sarioglu S, Sokmen S, Sakar M, Kupelioglu A, Fuzun M. 2005. Desmoplasia measured by computer assisted image analysis: an independent prognostic marker in colorectal carcinoma. Journal of Clinical Pathology 58:32-38.
60. Tuxhorn JA, McAlhany SJ, Dang TD, Ayala GE, Rowley DR. 2002. Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model. Cancer Research 62:3298-3307.
61. Vermeulen L, Todaro M, De Sousa Mello F, Sprick MR, Kemper K, Perez Alea M, Richel DJ, Stassi G, Medema JP. 2008. Single-cell cloning of colon cancer stem cells reveals a multilineage differentiation capacity. Proceedings of the National Academy of Sciences of the United States of America 105:13427-13432.
62. Vermeulen PB, Colpaert C, Salgado R, Royers R, Hellemans H, Van Den Heuvel E, Goovaerts G, Dirix LY, Van Marck E. 2001. Liver metastases from colorectal adenocarcinomas grow in three patterns with different angiogenesis and desmoplasia. Journal of Pathology 195:336-342.
63. Vermeulen PB, Gasparini G, Fox SB, Colpaert C, Marson LP, Gion M, Belien JA, De Waal RM, Van Marck E, Magnani E, Weidner N, Harris AL, Dirix LY. 2002. Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. European Journal of Cancer 38:1564-1579.
64. Weidner N, Semple JP, Welch WR, Folkman J. 1991. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. New England Journal of Medicine 324:1-8.
65. Weinberg RA. 2008. Coevolution in the tumor microenvironment. Nature Genetics 40:494-495.
66. Yan G, Zhou XY, Cai SJ, Zhang GH, Peng JJ, Du X. 2008. Lymphangiogenic and angiogenic microvessel density in human primary sporadic colorectal carcinoma. World Journal of Gastroenterology 14:101-107.